Costanzo M R, Naftel D C, Pritzker M R, Heilman J K, Boehmer J P, Brozena S C, Dec G W, Ventura H O, Kirklin J K, Bourge R C, Miller L W
Rush Heart Failure and Cardiac Transplant Program, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60614, USA.
J Heart Lung Transplant. 1998 Aug;17(8):744-53.
Controversy exists regarding donor and recipient factors that promote the development and progression of coronary artery disease after heart transplantation and the likelihood of coronary artery disease causing death or retransplantation.
To investigate this issue in a large cohort of patients, we analyzed 5963 postoperative angiograms performed in 2609 of the 3837 patients undergoing heart transplantation at 39 institutions between January 1990 and December 1994. Coronary artery disease was classified as mild, moderate, or severe on the basis of left main involvement, primary vessel stenoses, and branch stenoses. Coronary artery disease was considered severe if left main stenosis was > 70% or 2 or more primary vessels stenoses were > 70% or branch stenoses were > 70% in all 3 systems.
By the end of 5 years after heart transplantation, coronary artery disease was present in 42% of the patients, mild in 27%, moderate in 8%, and severe in 7%. Coronary artery disease-related events (death or retransplantation) had an actuarial incidence of 7% at 5 years and occurred in 2 of 3 of the patients with development of angiographically severe coronary artery disease. By multivariable logistic analysis, risk factors for donor coronary artery disease included older donor age (P < .0001) and donor hypertension (P=.0002). By multivariable analysis in the hazard function domain, risk factors identified for the earlier onset of allograft coronary artery disease included older donor age (P < .0001 ), donor male sex (P=.0006), donor hypertension (P=.07), recipient male sex (P=.02), and recipient black race (P=.01). The actuarial incidence of severe coronary artery disease was 9% at 5 years.
Angiographic coronary artery disease is very common after heart transplantation, occurring in approximately 42% of the patients by 5 years. Older donor age, donor hypertension, and male donor or recipient predict earlier onset of angiographic allograft coronary artery disease. Although severe angiographic allograft coronary artery disease occurs in only 7% of the patients at 5 years, its presence is highly predictive of subsequent coronary artery disease-related events or retransplantation.
关于心脏移植后促进冠状动脉疾病发展和进展的供体和受体因素,以及冠状动脉疾病导致死亡或再次移植的可能性,目前存在争议。
为了在大量患者队列中研究这个问题,我们分析了1990年1月至1994年12月期间在39家机构接受心脏移植的3837例患者中的2609例患者所进行的5963次术后血管造影。根据左主干受累情况、主要血管狭窄和分支狭窄,将冠状动脉疾病分为轻度、中度或重度。如果左主干狭窄>70%或2条或更多主要血管狭窄>70%或所有3个系统中的分支狭窄>70%,则冠状动脉疾病被认为是重度。
到心脏移植后5年末,42%的患者出现冠状动脉疾病,轻度的占27%,中度的占8%,重度的占7%。冠状动脉疾病相关事件(死亡或再次移植)的5年精算发病率为7%,在3例血管造影显示为重度冠状动脉疾病的患者中有2例发生。通过多变量逻辑分析,供体冠状动脉疾病的危险因素包括供体年龄较大(P<.0001)和供体高血压(P=.0002)。通过在风险函数领域的多变量分析,确定的同种异体冠状动脉疾病较早发病的危险因素包括供体年龄较大(P<.0001)、供体男性性别(P=.0006)、供体高血压(P=.07)、受体男性性别(P=.02)和受体黑人种族(P=.01)。重度冠状动脉疾病的5年精算发病率为9%。
心脏移植后血管造影显示的冠状动脉疾病非常常见,到5年时约42%的患者会出现。供体年龄较大、供体高血压以及供体或受体为男性预示着同种异体冠状动脉疾病血管造影发病较早。虽然5年时只有7%的患者出现血管造影显示的重度同种异体冠状动脉疾病,但其存在高度预示着随后的冠状动脉疾病相关事件或再次移植。